You are here:News Home» Topic» Aurobindo Pharma»
submit to reddit

'Aurobindo Pharma' - 13 Video Result(s)

'Aurobindo Pharma' - 192 News Result(s)

  • Lupin Falls as Rival Gets USFDA nod for Generic Suprax

    Lupin Falls as Rival Gets USFDA nod for Generic Suprax

    The approval by the USFDA is for strengths of 100 mg/5 ml and 200 mg/5 ml and the product is ready for launch, Aurobindo Pharma said in a statement.

  • Aurobindo Gets FDA Nod for Cefixime Oral Suspension

    Aurobindo Gets FDA Nod for Cefixime Oral Suspension

    Aurobindo Pharma today said it has got final approval from the US Food and Drug Administration (USFDA) to make and sell its generic version of oral suspension of antibiotic Cefixime.

  • Aurobindo Pharma Divests Australian arm to Eris Pharma

    Aurobindo Pharma Divests Australian arm to Eris Pharma

    APL will continue to manufacture and supply products to Eris Pharma for Australian and New Zealand markets over the next few years, it added.

  • Aurobindo Pharma, Plethico Pharmaceuticals Gain on Settlement of Dispute

    Aurobindo Pharma, Plethico Pharmaceuticals Gain on Settlement of Dispute

    Aurobindo Pharma today said Plethico will pay it $23.3 million to settle a dispute related to the acquisition of US-based Natrol.

  • Glenmark, Aurobindo Pharma Gain on Approval of Foreign Investment Proposals

    Glenmark, Aurobindo Pharma Gain on Approval of Foreign Investment Proposals

    Glenmark surged over 6 per cent to hit intraday high of Rs 898. The CCEA had yesterday cleared its proposal to increase foreign holding limit (FII limit) in the company to 49 per cent from 35.07 per cent now.

  • Cabinet Clears Rs 4,187-Crore Glenmark, Aurobindo Proposals

    Cabinet Clears Rs 4,187-Crore Glenmark, Aurobindo Proposals

    Foreign investment proposals worth Rs 4,187 crore of pharmaceutical majors Glenmark and Aurobindo were approved by the government on Tuesday.

  • Aurobindo Pharma, Torrent Pharma Jump on USFDA Approvals

    Aurobindo Pharma, Torrent Pharma Jump on USFDA Approvals

    The BSE healthcare index a sub-index of pharma and healthcare stocks was the top sectoral gainer supported by gains in pharma stocks.

  • Wipro, ONGC, Coal India in Focus Today

    Wipro, ONGC, Coal India in Focus Today

    The Nifty is likely to open flat on Monday as domestic stock markets open after a four-day break. Asian shares rose and the dollar dropped, after a dismal US jobs report raised hopes about a delayed interest rate hike in the US. Both foreign and dome...

  • Aurobindo Pharma Gets USFDA Nod for Sildenafil Injection

    Aurobindo Pharma Gets USFDA Nod for Sildenafil Injection

    The company has received approval from the US Food and Drug Administration (USFDA) to manufacture and market Sildenafil injection in the US market, Aurobindo Pharma Ltd said in a statement.

  • Aurobindo Pharma Shares Fall as Q3 Net Dips

    Aurobindo Pharma Shares Fall as Q3 Net Dips

    Total expenses for the quarter ended December 2014 came in at Rs 7,298 crore compared to Rs 6,279.5 crore during the same period last financial year.

  • HDFC Bank, Tata Motors, Bharti Airtel in Focus Today

    HDFC Bank, Tata Motors, Bharti Airtel in Focus Today

    Indian stock markets have fallen for four straight days and Thursday's opening is unlikely to provide confidence to investors. Most global markets have been weighed down by concerns over Greek debt problems. Foreign investors sold stocks in cash mark...

  • Aurobindo Pharma Q3 Net Down 8% at Rs 384 Crore

    Aurobindo Pharma Q3 Net Down 8% at Rs 384 Crore

    Aurobindo Pharma on Wednesday reported a 7.93 per cent decline in consolidated net profit at Rs 384.35 crore for the third quarter that ended on December 31, 2014.

  • Nifty Set to Rebound, Bharti Airtel, Hero MotoCorp in Focus

    Nifty Set to Rebound, Bharti Airtel, Hero MotoCorp in Focus

    The Nifty is likely to reverse its three-day losing streak on Wednesday tracking positive global cues. Foreign investors, who bought cash shares worth Rs 17,700 crore in January, sold shares worth Rs 264 crore yesterday; domestic investors sold share...

  • Nifty Set for Strong Start on ECB Trigger; Cairn India in Focus

    Nifty Set for Strong Start on ECB Trigger; Cairn India in Focus

    The Nifty is set to join a global rally on Friday triggered by the European Central Bank's $1.15 trillion stimulus announcement. Indian stock markets have gained for six straight sessions, buoyed by strong buying by foreign investors. On Thursday, FI...

  • Aurobindo Pharma to Raise $350 Million Through QIP

    Aurobindo Pharma to Raise $350 Million Through QIP

    The board had earlier constituted a securities issue committee comprising of five board members, including two independent directors, for issue of securities.

  • Aurobindo, Actavis Recall Gabapentin Capsules

    Aurobindo, Actavis Recall Gabapentin Capsules

    According to notification by the US Food and Drug Administration (USFDA), the Indian firm's arm Aurobindo Pharma USA Inc has initiated a Class II nation wide recall. Each bottle contains 100 capsules of 300 mg.

  • 2014: Pharma Deals Worth Billions, Fines Worth Millions

    2014: Pharma Deals Worth Billions, Fines Worth Millions

    It has been a year of bitter medicine for Indian pharmaceutical companies with fines worth millions of dollars imposed by various foreign regulators, even as they stitched together deals worth billions of dollars, including a high profile merger betw...

  • Wipro, OnMobile Global, Auro Pharma in Focus Today

    Wipro, OnMobile Global, Auro Pharma in Focus Today

    The Nifty opened lower on Friday as indicated by futures trade on Singapore Stock Exchange. Foreign investors turned net sellers of Indian equities with increased intensity as they have sold stocks worth Rs 808 crore on Thursday. However domestic inv...

  • Infosys, SpiceJet, ICICI Bank in Focus Today

    Infosys, SpiceJet, ICICI Bank in Focus Today

    The Nifty opened flat on Monday as indicated by futures trade on Singapore Stock Exchange. Foreign investors remained net sellers of Indian equities on Friday as they had sold stocks worth Rs 109 crore in cash market. However domestic investors were ...

  • Aurobindo Pharma Completes $132.5 Million Natrol Acquisition

    Aurobindo Pharma Completes $132.5 Million Natrol Acquisition

    Aurobindo Pharma acquired "manufacturing assets, personnel, commercial infrastructure including the nutraceuticals brands in USA of Natrol along with an agreement to take on certain liabilities, with a bid of $132.5 million", the company said in a st...

  • Aurobindo Pharma Unit Recalls Anti-Epilepsy Drug in US

    Aurobindo Pharma Unit Recalls Anti-Epilepsy Drug in US

    Aurobindo Pharmas US-based unit is voluntarily recalling a lot of Gabapentin capsules, an anti-epilepsy drug, in the American market, as some empty capsules were found in certain batches.

  • Aurobindo Pharma to Raise $350 Million via Securities

    Aurobindo Pharma to Raise $350 Million via Securities

    Aurobindo Pharma has said it will raise $350 million (around Rs 2,166 crore) through issue of securities for funding its business expansion.

  • Constable Suspected in Attack on Top Executive in Hyderabad

    Constable Suspected in Attack on Top Executive in Hyderabad

    The man who tried to kidnap a top industrialist in Hyderabad on Wednesday, armed with an AK 47, is allegedly a policeman who was part of the "Greyhounds", an elite anti-Naxal commando force.

  • Aurobindo Pharma Promoter Nityananda Reddy Attacked, Shares Choppy

    Aurobindo Pharma Promoter Nityananda Reddy Attacked, Shares Choppy

    Aurobindo Pharma director and vice chairman K Nityananda Reddy was attacked by an unidentified man in the posh Banjara Hills area of Hyderabad today.

Advertisement
Advertisement